• A case of nodular lichen myxedematosus
• A Case of Scleromyxedema Development Following Intravesical Bacillus Calmette-Guerin Administration
• A rare case of acral persistent papular mucinosis
• A Rare Case of Tumoral Scleromyxedema
• Acral lichen myxedematosus showing acro-osteolysis in a patient with Sjögren syndrome
• Acral persistent papular mucinosis
• Acral persistent papular mucinosis: A case report and summary of 24 Japanese cases
• Acute Encephalitic Syndrome Induced by Scleromyxedema
• Adverse reactions to the injection of face and neck aesthetic filling materials: a systematic review
• An atypical presentation of discrete papular mucinosis in the genitalia mimicking a molluscum contagiosum infection
• An unusual case of granulomatous scleromyxedema
• Autologous stem cell transplantation in a patient with scleromyxedema
• Case for diagnosis. Multiple infiltrated plaques in a patient with human immunodeficiency virus and hepatitis C co-infection: lichen myxedematosus
• Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL
• Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
• Characterization of circulating myeloma tumor cells by next generation flowcytometry in scleromyxedema patient: a case report
• Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
• Clinical and histopathological improvement of scleromyxedema-induced microstomia after hyaluronidase injection
• Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey
• Coexistence of scleromyxedema and Sneddon syndrome
• Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion
• Combination of Medical and Surgical Treatment in Scleromyxedema
• Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema
• Cutaneous manifestations of monoclonal gammopathy
• Dermato-neuro syndrome after COVID-19 infection in a patient with scleromyxoedema: Previously successful treatment with intravenous immunoglobulins
• Dermato-neuro Syndrome after COVID-19 Vaccination in a Patient with Scleromyxoedema Previously Controlled with Bortezomib and Intravenous Immunoglobulins
• Dermato-neuro syndrome-an acute and life-threatening complication of scleromyxedema Arndt-Gottron
• Dermoscopic and Cytological Findings in Scleromyxedema
• Discrete Acral Papular Mucinosis
• Doughnut Sign: A Tell-Tale Sign of Scleromyxedema
• Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
• Efficacy of intravenous immunoglobulins in severe scleromyxedema dysphagia assessed by oesophageal scintigraphy
• First report of histopathological and ultrasonographic correlation of localized lichen myxoedematosus
• Gammopathic dermopathy: characterization of cutaneous MGUS
• Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance
• Generalized Muscular Uptake of 99m Tc-MDP on Bone Scan in a Patient With Scleromyxedema-Associated Myopathy
• Generalized Muscular Uptake of 99mTc-MDP on Bone Scan in a Patient With Scleromyxedema-Associated Myopathy
• Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin
• Identifying the potential origin of mucin in primary cutaneous mucinoses-A retrospective study and analysis using histopathology and multiplex fluorescence staining
• IgG1 Subclass Restriction and Biochemical Peculiarities of Monoclonal Immunoglobulins in Scleromyxedema
• Immunologic and nonimmunologic sclerodermal skin conditions - review
• Immunotherapy-refractory vacuolar myopathy with mucin deposition in scleromyxedema: A possible role of fibroblast growth factor 2
• Isotretinoin for treatment of a challenging case of scleromyxoedema. Comment on 'Localized papulonodular facial eruption in HIV'
• Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient
• Lichen myxedematosus associated with monoclonal gammopathy of undetermined significance: A case report and literature review
• Lichen myxedematosus associated with pulmonary mucosa-associated lymphoid tissue lymphoma
• Lichen Myxedematosus: Case Report and Review of Literature
• Localized Scleromyxedema Masquerading as Angioedema
• Long-Term Efficacy of Treatment with Intravenous Immunoglobulin in Scleromyxedema
• Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know
• Mycophenolate mofetil treatment of an H syndrome patient with a SLC29A3 mutation
• New and emerging conditions of acquired cutaneous mucinoses in adults
• New insights on scleromyxedema
• Nodular lichen myxoedematous: a new adverse event associated with ustekinumab
• Nodular-Type Lichen Myxedematosus: A Rare Variant With Exclusive Involvement of the Hands-Report of Two Cases With a Comprehensive Review of the Literature
• Of lions, shar-pei, and doughnuts: a tale retold
• Papular Mucinosis
• Papular mucinosis associated with band acro-osteolysis: a new syndrome associated with connective tissue-disease
• Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema
• Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema
• Primary localized cutaneous lichen myxedematosus with light chain-restricted plasma cells: A distinct variant of the localized form of lichen myxedematosus
• Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema
• Rare scleromyxedema granuloma-annulare-like pattern successfully treated with intravenous immunoglobulins
• Renal injury in scleromyxoedema due to monoclonal gammopathy associated C3 glomerulonephritis
• Reticular Erythematous Mucinosis in an African Woman with HIV Infection: Case Report and Literature Review
• SARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema
• Scleroderma mimics - Clinical features and management
• Sclerodermalike syndromes: Great imitators
• Scleromyxedema
• Scleromyxedema
• Scleromyxedema
• Scleromyxedema
• Scleromyxedema and Hyperphosphatemia: Causal Relationship or Coincidence?
• Scleromyxedema and Underlying Multiple Myeloma
• Scleromyxedema associated with macular edema and retinal hemorrhage
• Scleromyxedema histopathologically mimicking hypercellular fibrous papules (angiofibomas): Case report of an unusual histopathological presentation
• Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report
• Scleromyxedema in a patient with thyroid disease: an atypical case or a case for revised criteria?
• Scleromyxedema in an adult following Sinopharm BBIBP-CorV vaccination: An extremely rare phenomenon
• Scleromyxedema treatment: a systematic review and update
• Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin
• Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins
• Scleromyxedema: A rare case report with dermoscopic findings
• Scleromyxoedema, blistering lesions and progressive sensorimotor neuropathy in Waldenstrom's macroglobulinaemia
• Self-healing juvenile cutaneous mucinosis, a sclerodermoid disorder simulating juvenile dermatomyositis: a case-based review
• Small lymphocytic lymphoma presenting as chronic diffuse lip swelling
• Solitary Cutaneous Focal Mucinosis
• Stem cell therapy in dermatology
• Successful Coronary Artery Bypass Grafting in a Patient With Uncontrolled Scleromyxedema
• Successful treatment of dermato-neuro syndrome with plasmapheresis
• Successful treatment of scleromyxedema with daratumumab, lenalidomide and dexamethasone in a patient with multiple myeloma
• Successful treatment of scleromyxoedema with daratumumab
• The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study
• Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
• Ungewohnliche Variante eines Skleromyxodems mit ausgepragter Systembeteiligung und atypischen Adnexproliferaten - Ein histologischer Stolperstein mit dem Risiko unnotiger Operationen: Unusual variant of scleromyxedema presenting with severe systemic invol
• Unusual type of scleromyxedema with multiple subcutaneous nodules, IgM-lambda paraproteinemia, and scleroderma-like microangiopathy
• Unusual type of scleromyxedema with multiple subcutaneous nodules, IgM-λ paraproteinemia, and scleroderma-like microangiopathy
• Unusual variant of scleromyxedema presenting with severe systemic involvement and atypical adnexal proliferations - A histological pitfall with the risk of unnecessary surgeries
• Versican deposits in the sclerotic skin of a patient with localized lichen myxedematosus accompanied by joint involvement
• Widespread, waxy, coalescing cutaneous papules